Internal Medicine, Hematology & Oncology · San Francisco, CA
NPI
1649733007
Since 2019
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2238 Geary Blvd
San Francisco, CA, 94115
Phone (415) 833-3692
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
200 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Nayha Tahir prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 20 prescriptions and refills. In total Nayha Tahir wrote 200 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-13.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Tagrisso Osimertinib Mesylate | 20 | 20 | Under 11 | $333K |
| Hydroxyurea Generic | 17 | 32 | Under 11 | $618 |
| Vitrakvi Larotrectinib Sulfate | 12 | 12 | Under 11 | $478K |
| Mirtazapine Generic | 11 | 13 | Under 11 | $120 |
Brand drugs: 60 claims; generic drugs: 140 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Nayha Tahir were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.